Optimum initial dose of silodosin for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia

We investigated the optimum initial dose and timing of administration of α1A-adrenoceptor antagonist silodosin for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH/LUTS). Ninety-eight patients were given a 4 mg dose after breakfast (group A), 4 mg after sup...

Description complète

Détails bibliographiques

Publié dans:	Hinyokika kiyo. Acta urologica Japonica. - 1962. - 57(2011), 6 vom: 31. Juni, Seite 297-302
Auteur principal:	Wada, Naoki (Auteur)
Autres auteurs:	Numata, Atsushi, Yamaguchi, Satoshi, Osanai, Hiroaki, Mori, Tatsuya, Hou, Kyokushin, Fujisawa, Makoto, Kaneko, Shigeo, Kakizaki, Hidehiro
Format:	Article
Langue:	Japanese
Publié:	2011
Accès à la collection:	Hinyokika kiyo. Acta urologica Japonica
Sujets:	English Abstract Journal Article Adrenergic alpha-1 Receptor Antagonists Indoles silodosin CUZ39LUY82